Citations Affected: IC 35-48-2-8.
Synopsis: Ephedrine and pseudoephedrine. Makes materials,
compounds, mixtures, or preparations that contain ephedrine or
pseudoephedrine schedule III controlled substances subject to being
dispensed only by a prescription.
Effective: July 1, 2011.
January 5, 2011, read first time and referred to Committee on Public Health.
A BILL FOR AN ACT to amend the Indiana Code concerning
criminal law and procedure.
quantity of controlled substances (1405).
(2) Benzphetamine (1228).
(3) Chlorphentermine (1645).
(4) Clortermine (1647).
(5) Phendimetrazine (1615).
(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system:
(1) Any compound, mixture, or preparation containing:
(A) amobarbital (2126);
(B) secobarbital (2316);
(C) pentobarbital (2271); or
(D) any of their salts;
and one (1) or more other active medicinal ingredients which are
not listed in any schedule.
(2) Any suppository dosage form containing:
(A) amobarbital (2126);
(B) secobarbital (2316);
(C) pentobarbital (2271); or
(D) any of their salts;
and approved by the Food and Drug Administration for marketing
only as a suppository.
(3) Any substance which contains any quantity of a derivative of
barbituric acid, or any salt thereof (2100).
(4) Chlorhexadol (2510).
(5) Embutramide (2020).
(6) Lysergic acid (7300).
(7) Lysergic acid amide (7310).
(8) Methyprylon (2575).
(9) Sulfondiethylmethane (2600).
(10) Sulfonethylmethane (2605).
(11) Sulfonmethane (2610).
(12) A combination product containing Tiletamine and
Zolazepam or any salt thereof (Telazol) (7295).
(13) Any drug product containing gamma-hydroxybutyric acid,
including its salts, isomers, and salts of isomers, for which an
application is approved under section 505 of the federal Food,
Drug and Cosmetic Act, 21 U.S.C. 301 et seq. (2012).
(d) Nalorphine (a narcotic drug) (9400).
(e) Narcotic Drugs. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs, or their salts calculated
as the free anhydrous base or alkaloid, in the following limited
quantities:
(1) Not more than 1.8 grams of codeine, per 100 milliliters or not
more than 90 milligrams per dosage unit, with an equal or greater
quantity of an isoquinoline alkaloid of opium (9803).
(2) Not more than 1.8 grams of codeine, per 100 milliliters or not
more than 90 milligrams per dosage unit, with one (1) or more
active, nonnarcotic ingredients in recognized therapeutic amounts
(9804).
(3) Not more than 300 milligrams of dihydrocodeinone, per 100
milliliters or not more than 15 milligrams per dosage unit, with a
fourfold or greater quantity of an isoquinoline alkaloid of opium
(9805).
(4) Not more than 300 milligrams of dihydrocodeinone, per 100
milliliters or not more than 15 milligrams per dosage unit, with
one (1) or more active nonnarcotic ingredients in recognized
therapeutic amounts (9806).
(5) Not more than 1.8 grams of dihydrocodeine, per 100 milliliters
or not more than 90 milligrams per dosage unit, with one (1) or
more active, nonnarcotic ingredients in recognized therapeutic
amounts (9807).
(6) Not more than 300 milligrams of ethylmorphine, per 100
milliliters or not more than 15 milligrams per dosage unit, with
one (1) or more active, nonnarcotic ingredients in recognized
therapeutic amounts (9808).
(7) Not more than 500 milligrams of opium per 100 milliliters or
per 100 grams or not more than 25 milligrams per dosage unit,
with one (1) or more active, nonnarcotic ingredients in recognized
therapeutic amounts (9809).
(8) Not more than 50 milligrams of morphine, per 100 milliliters
or per 100 grams with one (1) or more active nonnarcotic
ingredients in recognized therapeutic amounts (9810).
(9) Buprenorphine (9064).
(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21
U.S.C. 802(41)(B)).
(g) The board shall except by rule any compound, mixture, or
preparation containing any stimulant or depressant substance listed in
subsections (b) through (e) from the application of any part of this
article if the compound, mixture, or preparation contains one (1) or
more active medicinal ingredients not having a stimulant or depressant
effect on the central nervous system, and if the admixtures are included
therein in combinations, quantity, proportion, or concentration that
vitiate the potential for abuse of the substances which have a stimulant
or depressant effect on the central nervous system.
(h) Any material, compound, mixture, or preparation which contains
any quantity of Ketamine (7285).
(i) Hallucinogenic substances:
Dronabinol (synthetic) in sesame oil and encapsulated in a soft
gelatin capsule in a United States Food and Drug Administration
approved drug product (7369).
(j) A material, compound, mixture, or preparation that contains
a quantity of any of the following substances, pure or adulterated:
(1) Ephedrine.
(2) Pseudoephedrine.